ZEISS MYOCARE
How Does MyoCare Control Myopia Progression?
Zeiss MyoCare spectacles control myopia progression through the Cylindrical Annular Refractive Elements (C.A.R.E) technology incorporated across the lens segment. This C.A.R.E technology aims to deliver a “stop signal” to slow down progression of axial elongation.
1-3
The lens design consists of alternating defocus and correction zones in a ring-like pattern on the front surface, expanding towards the periphery of the lens. This creates simultaneous competing defocus.
2-6
Key Benefits & Features
Greater aesthetic for higher powered lenses due to extended range of 1.67 index lenses
ClearFocus design aims to ensure the optimal refractive correction according to the patient’s refractive demands and the intended myopic defocus are maintained for all gaze directions.
2-6
References
1. Chen X, et al. (2025, May 4-8). Slowing myopia progression with cylindrical annular refractive elements (CARE)- results from a 2-year prospective multi-central trial. The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Salt Lake City, UT, United States. (click here)
2. Alvarez-Peregrina, C., et al. (2025, May 4-8). Analysis of fast myopia progression and eye growth reversal in the Clinical Evaluation of MyoCare in Europe (CEME) study after 12 months wearing CARE lenses. The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Salt Lake City, UT, United States. (click here)
3. Alvarez-Peregrina, C., et al. Clinical Evaluation of MyoCare in Europe – the CEME Study Group. Clinical evaluation of MyoCare in Europe (CEME) for myopia management: One-year results. Ophthalmic Physiol Opt. 2025 Apr 29. (click here)
4. Ohlendorf, A., et al. (2025, May 4-8). Myopia progression in children: Comparison of progression one year before and during participation in a randomized controlled clinical trial. The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Salt Lake City, UT, United States. (click here)
5. Sankaridurg, P., et al. (2025, May 4-8). Myopia control efficacy in Asian versus European eyes with spectacle lenses incorporating cylindrical annular refractive elements (CARE). The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Salt Lake City, UT, United States. (click here)
6. Sanchez-Tena, M.A., et al. (2025, May 4-8). Adaptation and Visual Performance of CARE Spectacle Lenses: Findings from the Clinical Evaluation of MyoCare in Europe (CEME) Study. The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Salt Lake City, UT, United States. (click here)